Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update
Alexandru Burlacu, Simonetta Genovesi, Alberto Ortiz, Christian Combe, Carlo Basile, Daniel Schneditz, Frank van der Sande, Grigore T. Popa, Cornel Morosanu, Adrian Covic*, ERA-EDTA EUDIAL Working Group
Research output: Contribution to journal › Editorial › Academic › peer-review
Fingerprint
Dive into the research topics of 'Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update'. Together they form a unique fingerprint.